Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
>>Is the cat too far out of the bag to be stopped?<<
That is exactly what I am hoping would be the difficulty of Big $$ influencing politics. This trial is not just about ACTC, IT IS ABOUT THE THE SCIENCE OF CURES. That would be very troublesome to whomever (politicians) would aid, for financial gain, that of another party trying to prohibit humanity from receiving these cures for previously incurable diseases. I say diseases as in plural because I think we all know that if this trial is successful we are talking about a number of other treatments for which stem cells can be used.
Same here. Seen this many times before over the YEARS. I am just holding what I HAVE not getting excited or concerned. Let buyers and sellers do their emotional trading, but I most likely will be watching intently to pick up more shares on this specific "selling emotion".
>>Fact: Stem cell will kill the pharma industry.<<
Now that IS what worries me about this investment and getting too excited about the future. The future is ALWAYS an unknown. Pharmas with all their money and monopoly with drugs are definitely one of of the powers in the financial markets. All one has to do is watch a portion of CNBC market news and guaranteed you will hear about some pharmaceutical powerhouse ie. Pfizer, Merck, Abbot Labs, J&J etc. Are they going to let some small company with a product/service, that deems their drugs inferior and most likely useless, destroy their stronghold on the medical landscape? Believe me they have the power and influence in Congress to affect political governmental decision making. Last I checked the FDA is a government agency. I am sure this would not be the first time BIG $$$ has affected small business from political decision making pressure from big corps. My "hope' is that one of the big pharmas sees a different path to take - as in buying out or partnering, as opposed to squashing. But who knows? Thus the wonder of Wall Street and its financial ties to politics.
>>Market Value $193,148,618 a/o Jan 27, 2014<<
UNDERVALUED? If successful this will be valued far into the billions IMO. I feel that would be agreed upon by most all following this story. So more room for market value, based on share price, to grow. I personally would like to thank Rabin and his shenanigans (& hedgefund buddies?) for destroying the stock price for the years he served, making my purchases as low as they were. Now that he is gone it is time to let the price go.
Thank you for your "warnings", although I am pretty sure all who are here are pretty aware of all your revelations of distress this company has encountered. But please keep us up to date on the "dark side" of our investment.
Source is Venture Capital firm. Enough said! I never give any credibility to a firm that may have a personal financial stake or benefit from posting such negative info about a company they can profit on from decline in stock price. Capital firms lend money to many start ups in exchange for a boatload of shares and with that comes the power to possibly control the price of the stock for their personal benefit. Same situation exists for our financial supplier: Lincoln. This particular article reeks of personal motive for stating such opinion - can you say "short"?
>>Gary is GONE, and that can only be a good thing if the right replacement is found.<<
IMO a trained chimpanzee would be an improvement over our former CEO. At least the chimp would not INTENTIONALLY screw his shareholders.
I like that!! It would certainly instill more confidence in this shareholder. Plus bring some penalty to this man for taking advantage of his CEO position for his self serving financial reward.
Just wondering, as I personally celebrate the ousting of Rabin as CEO, if Lanza had something to do with Rabin's exit. Lets face it, this IS Lanza's baby. His knowledge and scientific discovery in this field IS the reason for the existence of this company. Without him there would be NO Advanced Cell Technology. Maybe he was displeased with Rabin's performance as CEO (DUH) and saw the "light" as he stood back and watched this man self indulge himself financially from this company going public. Fine if the sentiment of this company was euphoric or even positive to the "Street", but the diminishing share price, even with positive news, continued a troublesome downward trend. Isn't that one of the jobs of your front man and CEO of a publicly traded company - to excite WALL Street and potential investors about your company? The sinking share price surly shows the opposite. He (Rabin) has failed miserably with that CEO requirement. His personal greed and lack of shareholder concern has cast a severe shadow over this company and its exciting trials. Could Lanza feel that Rabin was a detriment to his science coming to fruition? I have said it before, Rabin as CEO got us to the trials, albiet from questionable financing. His leadership from this point (partnership, buyout, commercialization) was unqualified IMO. What he was qualified at, was funding his personal being. Good riddance and thank you Lanza if you had anything to do with his exit. Now just maybe your work and expertise will be appreciated and rewarded.
It would be nice if we heard some commentary from Dr. Lanza on this "good news" of Rabin's departure. After all, I feel most all shareholders who invested in this company invested because of his belief and involvement in this breakthrough science and not because of the "genius" mind of Rabin. I for one was very skeptical of this company because of Rabin, but very intrigued with Lanza and this science.
>>Gary was to temp step in as CEO until one was found & that was 4 years ago @ almost 1 million a year + stock options.<<
Thanks for reminding me of this. I remember quite well that this was the case. If my memory serves me correctly, Rabin was supposed to LEAD that search for a new CEO, but I am sure now that 4 years of pocketing that salary for himself was too much to turn down. In it for the science NOT the CEO! Anyone chuckling?
>>in connection with Mr. Rabin’s separation, the remaining members of the Board unanimously determined to reduce the size of the Board from six to five members.<<
HMMMM, Makes one wonder if that one member leaving at the same time as Rabin, might there be a connection between the two: as in his "connection" to the BOD with such favors received. This is getting more interesting as we go and hopefully we will be more enlightened to the shenanigans that took place during his tenure with more information that comes forward.
My feelings exactly. No scientist for CEO! If Lanza takes this position - I am OUT! This would smell funny to me. I would perceive this as LANZA wanting the salary that comes with this title as unethical and concerning. If he truly believes in the trials and science, his financial reward WILL be there for him. By taking such a position of CEO only raises interesting and concerning questions as to why. I have seen this happen previously as a doctor took control of the position of CEO which consequently resulted in a failure of investment for the shareholders.
WOW, was busy today and just sat down to check on "things" on the computer. The wicked witch is dead!! Now I know how Dorothy felt! Who or what got into the BOD to make this move? When did the obvious become apparent to them? What was their reasoning? I would love to hear their "official" reason for his stepping down, although it would just be sugar coated and not for what is the REAL reason - the one we all know! What makes this overdue news even more interesting to me is my speculation from previous hopes for a JV that our FORMER CEO (love that former part) would NO LONGER BE NEEDED IF A JV WAS IMMINENT. The partnering or purchasing enterprise has already one "in charge" in place, thus no need for RABIN"S EXPERTISE (or more realistically lack there of). Is one JV or buyout on the horizon? Without Rabin I have more confidence that shareholder value would be more of a priority when negotiating such.. Hopefully the new leader will be more qualified in the BIO/medical field along with business expertise. Now I'll go to our ACTC board - interested in seeing all your responses to this news.
"In it for the science NOT the CEO". OK start CHUCKLING! I have been speaking of the games being played on Wall Street and with this stock long before "your" revelation of such. As long as investing IS a form of gambling with potential lucrative pay days "long or short", there WILL be games played by manipulators. Crooks and shady tactics are always found around $$$ no matter where it is available. Wall Street is NO exception. Throw in a very low price, enormous amount of shares outstanding, a speculative stock with definite possibility and fear of trial failure along with a questionable CEO, it all makes it an easy task for price manipulation. All also creates investor uncertainty that are easily scared out of their shares. The science "to me" is way too intriguing with a possibility of an explosive stock price to not have a stake in such. The CEO and how much respect I feel he deserves makes the stake a modest one for me. Even with all the baggage I feel he brings to this company the reward from successful trials out weigh the aforementioned negative. Maybe now you understand the concept of "in it for the science NOT the CEO". But please continue your chuckling as I like making people laugh.
Very true. Way too many shares outstanding to finance from offerings of more shares. Partnership financing was no option without verifiable science to show. Trial was the only way to prove that. Thus possible/probable partnership financing when noticeable success is foreseen - hopefully in phase II.
The MMs ARE Lincoln, IMO. Owning so many shares in return for financing $$$, they can play with price as much as they want in order to satisfy their wants and needs. They can short the stock, hold it where it is, to accumulate more on the open market, or when they are satisfied with what they own, let the price go north. So goes the ways of Wall Street when financing through "Capital Companies". The only time they are not in control of the price is when 'news' hits thus causing an unusually large volume of trades making their attempts to move stock price more difficult. I have said it before - we are at their (Lincoln) mercy as long as this financing deal is in place and they hold "most" of the shares. Been there done that.
>>No Gary Rabin, so I do not know what that means<<
I know what it means to me. It means I am more apt to accept what was said as factual since the words did not come from both sides of his mouth.
BK??? I think you should explain. Could be interpreted as seriously troublesome.
Banned from further posting is just a minor worry for one making such negatively offensive statements of someones reputation without verifiable evidence to support such accusations. The consequences of such could be far more serious.
That is why it (reverse stock split and uplist) will have to coincide with positive news.
The reverse split AND extra shares entering the market have been known by the Street for some time now. With that said, IMO it (negativity) has been built into the price of where we are at. Thus the decline and stagnant movement. The company's informing to the public of the 20/400 to 20/40 was IMO planned as a buffer to coincide with the later "bad news" of future dilution and reverse stock split. As far as The CEO and Science being correlated, I disagree. The CEO and "company" are correlated, the science is what is - A new and breakthrough medical treatment that has the "potential" to shake the world of future medicine. I have said constantly and repeatedly that this IS IS IS a speculative investment and not for the conservatives (should buy treasury bonds), but one I am willing to take a shot at along with other speculators, due to such future euphoria if trial successful! Investing in Wall Street, without inside information, is in and of itself a gamble, don't let anyone tell you otherwise. Calculating risk/reward for each investment is mandatory for personal investors. In such an investment as this, I feel the reward by far outweighs the risk. Perhaps Molecular energy is where one should stay where they feel comfortable and investing in Wall Street should be avoided at all costs.
I have been in this stock for years. I have added along the way and have watched the price continuously during that time and have watched it drop from the highs of in and around the .20s. This is a possible great story but also a very speculative and unstable investment due to the price, # of outstanding shares, exchange (OTC) it is on, along with a "first time CEO" who I believe is in this position to financially enable himself first and foremost before his shareholders. Why do we not have a more qualified experienced CEO in the medical field? I believe its because of Rabin's GREED. This is not to say that the latter (shareholder value) will not happen. Even selfishness and egotism will not stop the science if verified. If this was the ONLY company trying to verify the science of stem cells, I would be more leery of this investment and CEO, but other companies also see something exciting about this science and its possible reshaping of the medical landscape, that they are also entering trials to participate in the use of this science. The first one will be rewarded the most, hopefully it will be ACTC. But even if not first, ALL will see price appreciation if just one stem cell trial is successful, thus verifying the science. As far as Rabin, IMO he has done nothing to deserve the confidence of his stockholders. His lone accomplishment has been getting the trials started. By getting the deal he negotiated with Lincoln Financial for $$$, thus dealing with a "Capital Company" in exchange for shares of stock, he created a situation and scenario that can be very painful to retail investors like us and IMO this is what is happening to us now. By owning a seriously substantial amount of shares, they (the financing companies) can become a controller of the price as it buys and sells at ease with so many shares. What is their intention? I do not know. Are they holding the price down to buy more on the open market? Are they shorting the stock (hedgefunds are notorious for this - hmm what was our CEO formerly?)? Only large volume of trading can override what they can do to the price -- and that will only occur when big news hits - as in trial results. There is really nothing we individual investors can do about it. I have said before that I am in this stock because it "could be", if trials are successful, the explosive stock and field (stem cells) of this era. Do I want to make $$$ - of course.
In it for the SCIENCE - NOT the CEO!
>>Whats not to like?,,<<
The CEO!
All good for those that want to add to their position!
I would not be totally surprised if this is happening as we speak (Rabin and his hedgefund buddies shorting our stock). Thus the questionable credibility of having a former hedgefund manager as our CEO. I will add as "THEY" hold/bring the price down and wait for when they and Lincoln decide it is time to let it go. Right now we, the retail investors, are at their mercy. Timing the market is not my cup of tea, but I do know one thing -- that when it is time for them to let the price rise, they will be well aware of the trial numbers beforehand and I will be "IN" taking advantage of this before that potential explosive news hits the media and Wall Street. Those not in, will be chasing the rising price. Is it a risk, YES, but one I'm willing to take in due to the reward. IN IT FOR THE SCIENCE NOT THE CEO.
I wish I could say I agree with you on this Willie but my fear with this type of financing with a capital company that receives a substantial amount of shares in return for financing, is that with owning that many shares, they can be self serving by controlling the price to their benefit by continuously holding the price down while accumulating shares for a rise in share price or profit from shorting the stock. Either way I have found that in the past with these type of finances, the retail shareholders are at the mercy of these capital companies with so many shares, as to when , if ever, they will allow the price to go north.
I honestly cannot say I disagree on that POST! Many others, yes I do disagree, but NOT that one.
Correct --- thus the low price at this juncture. It is up to every individual investor who follows this story to determine if because of all these other shenanigans the price is deflated, might this be a good time to enter or increase their holdings, thereby maximizing their profit from the news of settlement of these problems and/or positive trial updates. IMO it is. -- .06/share??
The science has to verified before any of them deserve a pat on the back. Until we (ACTC) get the green light from the FDA, this science will have its critics and naysayers. ONLY after that, will we be able to see the remarkable results of those believers who led the way to this future change in medical treatments. Until then, skeptics will be in abundance, as I am somewhat, but very hopeful that this remarkable new wave in medicine will be verified. Even though there is that bit of doubt in my mind, this, if approved, will be way too explosive to NOT have a position in this power to change the future. Being "IN" now, before major NEWS, is the only way to maximize one's profiting from this potential powerful reaction to the future positive events. To try and chase the price after such news, could be very disheartening knowing you could have bought at these low levels of price. To me its worth the risk/reward.
>>and can believe rabin<<
There's the million dollar question! I am one investor that needs to see much more progress and news before I will respect anything Rabin has to say. 'Truth' and "shareholder first" mentality seems to be lacking as one of our CEO's attributes. There is a saying I relate to for such matters in trusting someone: First time screwed - "shame on you". Second time screwed - "shame on me"! I would love to change my feeling about our CEO, but I would have to see something he is "excited about" come to fruition.
--In it for the science NOT the CEO!
>>BTW objective is stopping progression not cure<<
THAT, in itself, is a homerun for this investment! Recapturing LOST sight is a GRAND SLAM!!
>>Can't wait for TLD!<<
Same here. If we get the positive numbers we expect, even our hedgefund CEO can't screw it up. It would serve this company and all shareholders well if he would just announce the data and back off. Let the news itself work its own wonder on Wall Street. Let peer review journals, magazines, networks and brokerages (trough 'BUY" ratings) sing our song. Rabin has done enough damage to the "excitement" of these trials with his sideline shinanagins. He has found a way with his PERSONAL INTERESTS to harm this company in the eyes of potential investors. -- IT FOR THE SCIENCE NOT THE CEO!
I would think that would have been made public along with the included settlement, but thanks for the positve possibility. I don't have a good feeling of our BOD as to its handling of Rabin's punishment for such a selfish, unprofessional and potential illegal reporting (or non there of) of shares. Maybe, just maybe they (the BOD) need to be forced into such action. We as shareholders could only be so lucky.
>>I think we got off lightly.<<
I agree!
Great! Thanks for the good news. I still have time to buy more and add to my holdings at the repressed price drop resulting from such action. This is an opportunity that occurs only once a year with many stocks and I plan on taking advantage of this tax advantage year end selling. Thanks again ddls for the positve post!!
Where is the "bad" news from this announcement? If one thinks it is about Rabin's investigation by the SEC this to me is not bad news (also old news) but more of awakening to our BOD and hopefully putting pressure on them, that if they ARE his cronies, to forceably do something about this and remove this HEDGEFUND MANAGER from his self taken position and relinquish his ridiculous salary and appoint one more qualified to take this company forward. The coming to "light" of his shenanigins may now FORCE the BOD to act, like it or not. CRONIES or not they must act now or hear the intense displeasure of the stockholders -- Remember them, they ae the ones who paid this hedgefund manager his salary and THEY are the ones HE IS SUPPOSED TO BE WORKING FOR!! If the follow up to this is REMOVAL of our "hedgefund manager" as CEO, this is GOOD news. The info about possible share payments as compensation in law suits? -- Old news. Disclaimers always paint the most serious negative scenario.
"Fooled" I will not be if what you say occurs. I have said that I AM skeptical of this investment for various reasons, most of which stem from an amateuristic feeling I get about our CEO. The board of course is not to be excluded in that doubt since they appoint the CEO and in many cases on Wall Street they (BOD) have been known to be the cronies of the CEO. So I do not trust the BOD either. My point is, if they are NOT his cronies then they owe the stockholders the right to have the very best CEO IN position to maximize their investment by being "qualified" to take this revolutionary "product" and company to its utmost potential. I definitely do not see a HEDGEFUND MANAGER as that type of CEO. Why am I in it? I have said it before that this could be, if trials are successful, a news explosion. It will, IMO, seasily surpass the "irrational exuberance of the DOT COM era. To handsomely profit on that euphoria you must be in early at what I believe to be these prices before results are published, hold and add through all the BS and sell when you feel the news and euphoria has peaked (easier said than done) or when one feels comfortable with their gain. In no way am I ever trying to entice people into buying or selling because of what I state -- I am only voicing My opinion.
Rabin is an amateur CEO. He has no experience in this position that I know of. IMO he was brought in and "took" this position to get the company noticable on Wall Street. Thus his background in this markets as a hedgefund manager and dealing with publically held enterprises. His main original purpose was to obtain financing, public or private to generate enough cash to get the trials started. Mission accomplished! Now it is time to move on as if to assume that the trials will be successful and to bring in an accomplished CEO to bring this company to its next level of: commercialization, partnership or major buyout. But IMO Rabin will never give up his position nor the power and salary compensation that goes along with it. If he was SO INTERESTED in his stockholders he would step down as CEO, retain all his free shares and search for one CEO that is accomplished in the medical business field. This, if successful is too big for a former HEDGEFUND manager. He, and only he, is the reason I am skeptical about throwing "more" $$$ into this. NOT the SEC, NOT the outstanding shares, NOT the "noise" from this mesaage board--only because of our CEO. When/if he is removed I will consider this a "legitimate" investment. But as long as he remains I will have my doubts. --- In it for the SCIENCE not the CEO.
Old news